Journals / Erciyes Tıp Dergisi / 2008 / Cilt: 30 - Sayı: 1

Benign ve malign over tümörlü postmenopozal kadınlarda kist sıvısı ve serumda IGF-1, IGFBP-3 ve estradiol düzeylerinin karşılaştırılması

Comparison of IGF-1, IGFBP-3, and estradiol levels in Cyst fluid and serums of postmenopausal women with benign and malignant tumor

Pages
19–23
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies are required to understand the importance of microenvironment during tumor growth.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Ovarian cancer is the most significant cause of morbidity and mortality among gynecologic cancers.
📊
Key Findings & Data:In the present study, we compared the IGF-1, IGFBP-3, and estradiol levels in cyst fluid and serums of postmenopausal women with benign and malignant ovarian tumor.
💡
Conclusion & Impact:Further studies are required to understand the importance of microenvironment during tumor growth.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: Ovarian cancer is the most significant cause of morbidity and mortality among gynecologic cancers. Recently, effects of sex steroids and IGF/IGFBP system, which are the most important risk factors of ovarian cancer, has been investigated. In the present study, we compared the IGF-1, IGFBP-3, and estradiol levels in cyst fluid and serums of postmenopausal women with benign and malignant ovarian tumor. Materials and Methods: In total, 28 patients,12 patients with malignant ovarian tumor and 16 patients with benign ovarian tumor, were included in the study. In order to minimize the hormonal changes taking place during menstrual cycle, only postmenopausal patients were included in the present study. IGF-1, IGFBP-3, and estradiol levels were measured in cyst fluid and serums.Results: Estradiol level in cyst fluid of patients with malignant ovarian tumor, was significantly high. IGF-1 and IGFBP-3 levels measured in cyst fluid and serums, did not show a significant difference between patients with benign and malignant ovarian tumors.Conclusion: The present study supported the hypothesis proposing an association between estradiol and ovarian carcinogenesis. Further studies are required to understand the importance of microenvironment during tumor growth.

Özet

Amaç: Over kanseri jinekolojik kanserler arasında morbidite ve mortalitenin en önemli nedenidir. Over kanserinin en önemli risk faktörleri olan sex steroidler ve IGF/IGFBP sisteminin etkileri son yıllarda araştırılmaktadır. Bu çalışma da benign ve malign over tümörlü postmenapozal kadınlarda, serum ve kist sıvısında IGF-1, IGFBP-3 ve estradiol düzeyleri karşılaştırıldı. Gereç ve Yöntemler: Çalışmaya malign over tümörlü 12 hasta ve benign over tümörlü olan 16 hasta olmak üzere toplam 28 hasta katıldı. Menstrüel siklus boyunca meydana gelen hormonal değişiklikleri en aza indirgemek için sadece postmenopozal hastalar çalışmaya dahil edildi. Serum ve kist sıvısında IGF-1, IGFBP-3 ve estradiol düzeyi ölçüldü.Bulgular: Malign over tümörlü hastaların kist sıvısında estradiol düzeyi anlamlı olarak yüksekti. Serum ve kist sıvısı IGF-1 ve IGFBP-3 düzeyi benign ve malign over tümörlü hastalarda anlamlı fark göstermedi.Sonuç: Bu çalışma ile estradiol ile ovarian karsinogenezis arasındaki ilişkiyi savunan hipotez desteklenmektedir. Tümör büyümesinde mikroçevrenin önemini anlamak için gelecekteki çalışmalara ihtiyaç vardır.

🔖

Cite This Article

ÖZÇELİK, B., SERİN, İ. S., DİNÇER, C., TANRIVERDİ, F., ÜNLÜHIZARCI, K. (2022). Benign ve malign over tümörlü postmenopozal kadınlarda kist sıvısı ve serumda IGF-1, IGFBP-3 ve estradiol düzeylerinin karşılaştırılması. Erciyes Tıp Dergisi, Cilt: 30 - Sayı: 1, 19–23. https://ajindex.com/articles/502651

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Poels LG, Jap PH, Ramaekers FF et al. Characterisation of a hormone producing ovarian carcinoma cell line. Gynecol Oncol 1989; 32:203-214
  2. Wimalasena J, Meehan D, Cavallo C. Human epithelial ovarian cancer cell steroid secretion and its control by gonadotropins. Gynecol Oncol 1991; 41:56-63
  3. Karasik A, Menczer J, Pariente C, Kanety H. Insulin-like growth factor-1 (IGF-1) and IGF- binding protein-2 are increased in cyst fluids of epithelial ovarian cancer. J Clinical Endocrinoloy and Metabolism 1994; 78:271-276… 4. Cohen P, Lamson G, Okajima T Rosenfelt RG. Transfection of the human IGFBP-3 gene into Balb/c fibroblasts inhibits cellular growth. Mol Endocrinol 1993; 7:380-386
  4. De Mellow JS, Baxter RC. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-1-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 1988; 156:199-204
  5. Conover CA. Potentiation of insulin-like growth factor (IGF) action by IGF binding protein-3: stuiesof underlying mechanisms. Endocrinology 1992; 130:3191-3199
  6. Speroff L, Fritzz MA. Menopause an the Perimenopausal Transition in the Clinical Gynecologic Endocrinology and Infertility. 7th ed. Philedelphia: Lippincott Williams and Wilkins; 2004 8. Daughaday WH, Rotwein P. Insuli-like growth factos I and II. Peptide, messinger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr Rev 1989; 10:68-91 9. LeRoith D, Roberts CT Jr. The insulin-like growth system and cancer. Cancer Lett 2003; 195:127-137
  7. Lukanova A, Lundin E, Toniolo P, et al. Circulating levels of insulin-like growth factor-1 and risk of ovarian cancer. Int J Cancer 2002; 101:549-554
  8. Lukanova A, Lundin E, Micheli A, et al. Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy). Cancer Causes Control 2003; 14:285-292
  9. Rocha RL, Hilsenbeck SG, Jackson JG, Lee AV, Figuero JA, Yee D. Correlation of insulin-like growth factor binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst 1996; 88:601-606
  10. Flyvbjerg A, Mogensen O, Mogensen B, Nielsen OS. Elevated serum insulin-like growth factor binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhib